Corneal Transplant Rejections in Patients Receiving Immune Checkpoint Inhibitors

Immune checkpoint inhibitor-associated ophthalmic adverse events: current understanding of its mechanisms, diagnosis, and management

(2022) Yu-Wen Zhou et al.   International Journal of Ophthalmology

Transplant rejections associated with immune checkpoint inhibitors: A pharmacovigilance study and systematic literature review

(2021) Lee S. Nguyen et al.   EUROPEAN JOURNAL OF CANCER

Next generation of immune checkpoint inhibitors and beyond

(2021) Julian A. Marin-Acevedo et al.   Journal of Hematology & Oncology

The Safety and Efficacy of Checkpoint Inhibitors in Transplant Recipients: A Case Series and Systematic Review of Literature

(2020) Vivek Kumar et al.   ONCOLOGIST

Bilateral Corneal Graft Rejection Associated With Pembrolizumab Treatment

(2020) Eva Vanhonsebrouck et al.   CORNEA

Review of Indications of FDA-Approved Immune Checkpoint Inhibitors per NCCN Guidelines with the Level of Evidence

(2020) Raju K. Vaddepally et al.   Cancers

Immune Checkpoints Contribute Corneal Immune Privilege: Implications for Dry Eye Associated with Checkpoint Inhibitors

(2020) Junko Hori et al.   INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES

A decade of immune-checkpoint inhibitors in cancer therapy

(2020) Caroline Robert   Nature Communications

Immune checkpoint inhibitors and corneal transplant rejection: a call for awareness

(2020) Harpal Singh Sandhu et al.   Immunotherapy

Programmed Cell Death 1 (PD-1) Inhibitors in Renal Transplant Patients with Advanced Cancer: A Double-Edged Sword?

(2019) Hung-Chih Lai et al.   INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES

Literature review and suggested protocol for prevention and treatment of corneal graft rejection

(2019) Otavio Azevedo Magalhaes et al.   EYE

The Intriguing History of Cancer Immunotherapy

(2019) Paula Dobosz et al.   Frontiers in Immunology

CHECKPOINT INHIBITOR IMMUNE THERAPY

(2018) Lauren A. Dalvin et al.   RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES

Fundamental Mechanisms of Immune Checkpoint Blockade Therapy

(2018) Spencer C. Wei et al.   Cancer Discovery

Immune Checkpoint Inhibitors and the Risk of Allograft Rejection: A Comprehensive Analysis on an Emerging Issue

(2018) Luis E. Aguirre et al.   ONCOLOGIST

Acute renal allograft rejection after immune checkpoint inhibitor therapy for metastatic melanoma

(2016) L. Spain et al.   ANNALS OF ONCOLOGY

Cardiac allograft rejection as a complication of PD-1 checkpoint blockade for cancer immunotherapy: a case report

(2016) Taofeek K. Owonikoko et al.   CANCER IMMUNOLOGY IMMUNOTHERAPY

Corneal graft rejection in a patient treated with nivolumab for primary lung cancer

(2016) S. Le Fournis et al.   LUNG CANCER

Antitumor activity of nivolumab on hemodialysis after renal allograft rejection

(2016) Michael Ong et al.   Journal for ImmunoTherapy of Cancer

Immune evasion in cancer: Mechanistic basis and therapeutic strategies

(2015) Dass S. Vinay et al.   SEMINARS IN CANCER BIOLOGY

Human Tumor Antigens and Cancer Immunotherapy

(2015) Nathalie Vigneron   Biomed Research International